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Prolactin Mediated Intracellular Signaling in Mammary
Epithelial Cells
Nancy E. Hynes,1-3 Nathalie Cella,1 and Markus Wartmann2
Prolactin binds to a member of the cytokine receptor superfamily. The cytoplasmic domain
of the prolactin receptor (PrlR)4 displays no enzymatic activity yet prolactin treatment leads
to the induction of protein tyrosine phosphorylation. PrlR is associated with JAK2, a protein
tyrosine kinase whose activity is stimulated following receptor dimerization. JAK2 subsequently
phosphorylates PrlR and other cellular proteins which are recruited to the activated receptor
complex. Among the JAK2 substrates is the transcription factor Stat5 whose phosphorylation
mediates the transcriptional activation of p-casein gene expression. In this review we discuss
the prolactin induced signaling pathways which mediate differentiation of the mammary gland.
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INTRODUCTION
Differentiation of the mammary gland requires
the coordinated action of growth factors and hormones
which promote morphological development and milk
protein production in the lactating gland (1). Much of
our current understanding of the intracellular signaling
pathways activated by prolactin stems from experi-
ments with mammary epithelial cells, cells that differ-
entiate in response to this hormone. In addition, the
Nb2 lymphoma cells, which are dependent upon pro-
lactin for proliferation have provided another valuable
system for examining prolactin action. The prolactin
receptor (PrlR) is a member of the cytokine receptor
superfamily (2). These receptors have no intrinsic
kinase activity. However, they are associated with
members of the Janus kinase (JAK) family of protein
tyrosine kinases. Following ligand-induced receptor
aggregation, JAK is activated and phosphorylates cel-
lular proteins on tyrosine residues. Transcription fac-
tors of the signal transducer and activator of
transcription (Stat) family are among the most
important of the JAK substrates. Stats are latent cyto-
plasmic transcription factors which, when phosphory-
lated on tyrosine, activate transcription of their
target genes.
The promoter region of the gene encoding the
milk protein p-casein has binding sites for numerous
transcription factors which confer both positive and
negative regulation on its expression (3-8). One of
these factors, indispensable for hormonal induction of
P-casein gene transcription, binds to a conserved, IFN-
•v activated (GAS)-like sequence present in the pro-
moter of casein genes from different species (3). This
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factor is the mammary gland factor (MGF), a member
of the Stat family, also known as Stat5 (9; reviewed
in 10).
The discovery of the JAK-STAT pathway by sci-
entists working on interferon (IFN) responsive tran-
scription factors (reviewed in 11) has provided fresh
insight into prolactin-mediated mammary differentia-
tion. Intracellular signaling molecules downstream
from the PrlR associated JAK are the main topic of
this review. For an excellent review on other signaling
pathways activated by prolactin the reader is referred
to Reference 12.
PROLACTIN INDUCED SIGNALING IN
MAMMARY EPITHELIAL CELLS
The molecular events triggering the process of
mammary differentiation have been examined by
employing an in vitro cell culture system. HC11 mam-
mary epithelial cells synthesize (i-casein in response
to the lactogenic hormones glucocorticoids, insulin and
prolactin (13-15), all three of which are required for (3-
casein gene expression (16). This observation suggests
that multiple signals converge on the (3-casein gene
and contribute to its transcriptional activation. HC11
cells have been used to explore the pathways by which
this occurs. Where possible, the results obtained with
mammary cells will be discussed in the context of the
mitogenic effects of prolactin on Nb2 cells.
The Prolactin Receptor
PrlR has multiple forms, identical in the extracel-
lular ligand binding domain but differing in their cyto-
plasmic portion (17,18). The short and long form of
the receptor have cytoplasmic domains of 57 and 357
amino acids, respectively. HC11 cells, like the mouse
mammary cells from which they were isolated, express
the long form of the PrlR (19). Nb2 cells express an
intermediate form of PrlR in which 198 amino acids
of the central cytoplasmic portion of the long form are
genetically deleted (20).
The initial intriguing results on prolactin mediated
signaling came from an examination of the ability of
the various PrlRs to induce 3-casein gene transcription.
Ectopic expression of the three PrlRs revealed that the
short form of the receptor does not mediate [3-casein
gene transcription, whereas the intermediate and long
forms of PrlR are able to activate transcription of this
gene (21,22). Similarly, when the three forms of PrlR
were tested for induction IRF-1, a prolactin-induced
early response gene in Nb2 cells, only the long and
intermediate forms were able to activate its transcrip-
tion (23) and were mitogenically competent in cells
requiring prolactin for growth (24).
JAK2
Despite the fact that cytokine receptors have no
intrinsic tyrosine kinase activity, ligand triggered
dimerization of PrlR leads to the rapid appearance
of phosphotyrosine-containing proteins (25). Cytokine
receptors associate with and activate the JAK family of
protein tyrosine kinases. There are four JAKs: JAK1,
JAK2, JAK3 and Tyk2. These proteins have two char-
acteristics which distinguish them from the Src-family
of cytoplasmic tyrosine kinases: JAKs possess a kinase
and a kinase-like domain and they do not have a phos-
photyrosine-binding, Src homology 2 (SH2) domain
(reviewed in 26). The cytoplasmic domain of PrlR is
non-covalently associated with JAK2 (27,28). Interest-
ingly, JAK2 appears to be associated with both the PrlR
(29) and Erythropoietin receptor (EpoR) (30) even in
the absence of ligand binding. In contrast, JAK2 bind-
ing to the growth hormone (GH) receptor is dependent
on GH binding (31).
The region of the PrlR required for JAK2 binding
has been examined and the difference in the signaling
potential of the long, intermediate and short forms of
PrlR can be explained by their differential ability to
activate JAK2. In the membrane-proximal cytoplasmic
domain of cytokine receptors there are two regions,
boxl and box2, which share limited similarity among
the receptors. The long and intermediate forms of PrlR
have both conserved domains, whereas the short form
contains only the proline-rich boxl. Experimental evi-
dence obtained from transfecting natural forms of PrlR
as well as mutant receptors into various cells shows
that the cytoplasmic, juxtamembrane region of PrlR
binds JAK2. Furthermore, PrlRs which are lacking
boxl and box2 neither mediate JAK2 binding nor its
activation in response to prolactin (24,32). Hormone
induced activation of JAK2 is also impaired in cells
expressing EpoR mutants lacking boxl (30). The abil-
ity of a particular form of PrlR to bind JAK2 provides
an explanation for the different signaling potential of
the receptors.
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Stat5
When prolactin binds the intermediate and long
forms of PrlR there is an increase in the phosphotyro-
sine content of JAK2 reflecting its elevated kinase
activity. Activated J AK2 in turn phosphorylates the PrlR
on Tyr residues (27,33). The phosphorylated residues of
the receptor have the potential to serve as docking sites
for SH2 and phosphotyrosine-binding domain (PTB)-
containing intracellular signaling molecules.
Stat proteins, which are latent cytoplasmic tran-
scription factors, are an important class of PrlR binding
proteins. JAKs are the upstream activators of Stats. To
date, seven Stats encoded by different genes have been
identified: Statl, 2, 3, 4, 5a, 5b, and 6. It is now
recognized that many cytokines and peptide growth
factors activate the JAK-Stat pathway. JAKs phospho-
rylate Stats on a single Tyr residue leading to their
activation, a process involving Stat dimerization,
nuclear translocation and DNA binding. Tyr phosphor-
ylated Stats specifically bind DNA at GAS-like sites
leading to transcriptional activation of target genes
(Fig. 1) (reviewed in 11).
The phosphorylation of Stat5(MGF) on Tyr694
is essential for the prolactin response since replacement
of Tyr694 by Phe prevents Stat5 Tyr phosphorylation,
DNA binding and transcriptional activation of the (3-
casein gene (34). Prolactin induced activation of StatS
has been reported in mouse, rat and rabbit mammary
cells (35-37). Two Stat5 proteins, Stat5a and Stat5b,
the products of two closely related genes, are expressed
in mouse mammary epithelial cells (38) and prolactin
mediates the Tyr phosphorylation of both StatSa and
Stat5b in HC11 cells (Fig. 2). Stat5 Tyr phosphoryla-
tion is maximal after 5-10 min. of prolactin treatment
then drops and remains constant over at least 2 days of
lactogen treatment (Fig. 2 and N. Cella, unpublished).
Stat5 appears to be the main activator of p-casein
transcription in HC11 cells since it is the only Stat
detected in an electrophoretic mobility shift assay
(EMSA) using a specific GAS-like oligonucleotide
from the p-casein gene promoter (N. Cella unpublished
results). Prolactin induced activation of Stall, Stat3,
and Stat5 has been observed in Nb2 lymphoma cells
and in T47D human breast tumor cells (39-41). How-
ever, we have not observed prolactin-induced Stat1
aclivation in HC11 cells (N. Cella unpublished results).
Whether or not Stall or Slal3 are aclivated by prolactin
in mammary cells in vivo is not known.
Phosphorylated Tyr residues serve as docking
sites for cytoplasmic proteins which, when recruited
to an activated receptor tyrosine kinase (RTK), mediate
the stimulalion of numerous intracellular signaling
pathways. Compared to RTKs where a wealth of
knowledge exists concerning the phosphotyrosine resi-
dues recognized by different signaling molecules (42),
there is only limited knowledge about the recognition
specificity of proteins which bind the PrlR. Attempts
have been made to identify the phosphorylated Tyr
residue(s) of the PrlR which binds Stat5. There are
five conserved Tyr residues in the cytoplasmic domain
of the long form of the PrlR. Using the numbering for
the rat PrlR, these are: Tyr237, 402, 479, 515, and 580
(41). A PrlR in which Tyr580 is replaced by Phe has
a reduced ability to trancriptionally activate the p-
casein gene following its ecotopic expression in
transfected cells (43). This suggesls that Stat5 binding
to Tyr580 of the PrlR is important for its JAK2-medi-
ated phosphorylation. It is noteworthy that the interme-
diate form of the PrlR, present in Nb2 cells has the
equivalent of Tyr 580 and is capable of transmitting
a mitogenic as well as a lactogenic signal.
Stat5 couples to many members of the cytokine
superfamily of receptors, including the EpoR, the IL-
2 receptor and the granulocyte-macrophage colony
stimulating factor (GM-CSF) receptor (11). This
allows a comparison of Tyr580 with the other phos-
phorylated Tyr residues which potentially bind Stat5.
The sequence surrounding Tyr580 of the PrlR
-LDY580LDPT- exhibits homology with the sequence
surrounding Tyr343 of the EpoR -DTY343LVLD-
(44,45) and TyrSlO of the IL-2 receptor p-chain
-DAY510LSLQ- (46), two other sites which have been
shown to be involved in Stat5 binding. However, the
sequence surrounding Tyr392 of the IL-2 receptor P-
chain -DAY392CTFP- which has also been implicated
in Stat5 activation shows less similarity to the sequence
surrounding Tyr580. In addition, a PrlR lacking Tyr580
and containing only 94 amino acids in the cytoplasmic
domain, was able to mediate Tyr phosphorylation of
Stat5 (41) and transmit a growth stimulus when intro-
duced into 32D cells (24). Finally, mutants of the GM-
CSF receptor have been tested for their ability to medi-
ate phosphorylation of Stat5 and transcriptional activa-
tion of the p-casein promoter. Interestingly, a GM-
CSF receptor mutant devoid of Tyr residues but able
to activate JAK2 is capable of mediating Stat5 phos-
phorylation and stimulating P-casein transcription
(47).
Although the experiments with mutated receptors
present an artificial situation, some important conclu-
sions can be drawn from them. Activation of a JAK
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Fig. 1. Prolactin induced signaling. Binding of prolactin to the extracellular domain of
the receptor induces dimerization and activation of the Tyr kinase JAK2 associated with
the cytoplasmic domain of PrlR. Some of the substrates for JAK2 are indicated. These
include: PrlR, StatS, She, and SHP-2. Tyr phosphorylation of StatS, a latent cytoplasmic
transcription factor, promotes its dimerization, nuclear translocation and transcriptional
activation of target genes following binding to GAS-like recognition sites. Tyr phosphory-
lated She connects PrlR to the MAP kinase pathway via binding to the Grb-2/SOS
complex (indicated by arrows). This complex in turn, activates Ras and the downstream
signaling molecules Raf, MEK, and MAPK. SHP-2 has a positive effect on (3-casein
gene transcription via its specific protein tyrosine phosphatase activity. The figure is a
composite of information on prolactin signaling in mammary cells and in Nb2 lymphoma
cells. For details and references see the text.
appears to be absolutely essential for signal transmis-
sion and in the normal situation a Stat very likely
binds a particular phosphotyrosine site on a cytokine
receptor. However, this interaction is not necessary for
Stat phosphorylation and it is possible that JAK may
in some cases function both as a docking protein and
as a Tyr kinase for a Stat. Tyr phosphorylation of the
receptor may not be essential for all aspects of signal-
ing and, at least in an artificial system, appears to be
expendable for transcriptional activation of (3-casein
(47). It is interesting to speculate that some of the
conserved Tyr residues present in the cytoplasmic
domain of the PrlR may couple to proteins involved
in "fine-tuning" the prolactin signal. The Nb2 cell line
which expresses the intermediate form of the PrlR is
very sensitive to prolactin yet its PrlR is not heavily
phosphorylated on Tyr residues (25). The intermediate
PrlR may lack conserved Tyr residues potentially
important for down-regulation of the prolactin signal.
The MAP Kinase Pathway
Mitogen-activated protein (MAP) kinase cas-
cades are conserved intracellular signaling pathways
Prolactin Signaling in Mammary Epithelial Cells 23
Fig. 2. Prolactin mediated Tyr phosphorylation of Stat5 and She,
and activation of p42 ERK2 MAP kinase. Stat5a, She and the
p42 ERK2 isoform of MAP kinase were immunoprecipitated from
control, prolactin (P) and lactogenic hormone (DIP) treated HC11
cells. The Stat5a (upper panel) and She (middle panel) samples
were electrophoresed, blotted and probed with a phosphotyrosine
specific mAb. Tyr phosphorylation on Stat5 is maximum after 10
min of treatment and drops by 60 min. There is a basal level
of Tyr phosphorylation on She under the conditions used in the
experiment (c) and only the p52 and p46 She isoforms display an
increase in phosphotyrosine following both treatments. An in vitro
kinase assay was performed with p42 ERK2 MAP kinase using
myelin basic protein (MBP) as a substrate (lower panel). MAP
kinase activity is more strongly stimulated by DIP than P due
to the combined effect of insulin and prolactin in the lactogenic
hormone mix.
by which cells respond to a variety of external stimuli
including hormones, cytokines and growth factors
(48). In mammalian cells the 44 kDa and 42 kDa
extracellular-signal-regulated kinases (ERKs) are
members of the archetype MAP kinase cascade. Gener-
ally, ERK1 and ERK2 are activated by the sequential
stimulation of Ras, a small GTP binding protein, Raf-
1, a 74 kDa Ser/Thr kinase and MEK, a dual specificity
kinase which activates ERK1 and ERK2 by phosphor-
ylation on a both a Thr residue and a Tyr residue.
ERK1 and ERK2 are broad-specificity kinases which
recognize Ser/Thr in context of Pro residues. There is
great interest in MAP kinase cascades since, among
the substrates of ERKs, are transcription factors whose
activity is altered by phosphorylation. Thus, MAP
kinases transmit a signal from outside the cell into the
nucleus thereby influencing its phenotype (Fig. 1).
The MAP kinase pathway is coupled to activated
RTKs via the She adaptor protein. She binds to phos-
photyrosine residues in many RTKs via its PTB bind-
ing domain which recognizes -NXXYP- (49). She in
turn is phosphorylated on Tyr and serves as a docking
site for the Grb-2/Son of Sevenless (SOS) complex.
The relocalization of SOS, the Ras-GTP exchange fac-
tor, to the inner surface of the plasma membrane allows
it to exchange GDP on Ras for GTP, thus activating Ras
and the downstream components of the MAP kinase
cascade (Fig. 1). She is phosphorylated on Tyr follow-
ing addition of prolactin to HC11 cells (Fig. 2) and
Nb2 lymphoma cells (50). None of the conserved Tyr
residues in the PrlR are in a consensus PTB binding
domain. This suggests that She may bind activated,
phosphorylated JAK2 and directly serve as a substrate.
In fact, the JAK2 sequence has a Tyr residue in a
potential PTB recognition site (51). Although it is not
yet known whether this Tyr is autophosphorylated by
JAK2, it has been observed that She coimmunoprecipi-
tates with JAK2 (50). In addition to She phosphoryla-
tion, treatment of HC 11 cells with lactogenic hormones
leads to the rapid activation of Raf-1, MEK1 and ERK2
(52 and Fig. 2). Nb2 cells treated with prolactin display
an elevation in Ras-GTP levels and Raf-1 kinase activ-
ity (50,53). There is also a rapid appearance of ERK1
in the nucleus of these cells (54). See the chapter by
Das and Vonderhaar for a more detailed discussion of
the role of MAP kinase in prolactin induced
mitogenesis.
Whilst experimental evidence attests to activation
of the MAP kinase cascade by prolactin, the role of
ERKs in prolactin induced mammary differentiation
is not yet clear. Potential MAP kinase substrates are
Stat5 itself as well as other transcription factors which
play a role in lactogenic hormone induced transcription
of milk protein genes. Although it is clear that Tyr-
phosphorylation is necessary for Stat DNA binding,
whether or not this phosphorylation is sufficient to
promote transcriptional activation is now being investi-
gated in various systems including mammary cells.
Due to the diversity of signals which lead to Stat
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activation, as well as the numerous genes whose tran-
scription is stimulated in response to a particular Stat,
it is unlikely that there will be a simple answer.
The COOH termini of Stat la and Stat3 have a
consensus MAP kinase site -PXS/TP- which is phos-
phorylated in response to interferon (IFN). A mutant
Stat la in which the Ser in the consensus MAP kinase
site was changed to Ala binds DNA as well as wild
type. However, transcriptional activation of an IFN-y
responsive gene was reduced in cells expressing the
mutant (55). Currently only indirect evidence suggests
that it is MAP kinase which phosphorylates this site
(discussed in 56). However, these experiments clearly
show that Ser phosphorylation can contribute to the
transcriptional activation potential of Stats.
Stat5 is phosphorylated on Tyr and Ser residues
in lactogen-treated HC11 cells (52), in IL-2 stimulated
T cells (57) and in liver cells from GH treated rats
(58). Since the MAP kinase signaling pathway is acti-
vated by prolactin, the role of this pathway in the
differentiation of HC11 cells was examined using the
MAP kinase kinase (MEK) specific inhibitor PD98059
(59). Pretreatment of HC11 cells with PD98059 led
to repression of lactogenic-hormone induced ERK2
MAP kinase activity but had no effect on the Ser
phosphorylation of Stat5, on its DNA binding activity
or on lactogenic hormone induced transcriptional acti-
vation of the (i-casein promoter luciferase construct
(52). These data demonstrate that MAP kinase activa-
tion is not involved in Ser phosphorylation of Stat5
or in the transcriptional induction of the (3-casein gene
mediated by lactogenic hormones.
Protein Tyrosine Phosphatase SHP-2
JAK2 mediates the initiation of the prolactin sig-
nal. Since Tyr phosphorylation is transient, it is likely
that protein tyrosine phosphatases (PTPs) are involved
in some aspect of signal termination. However, little
is known about the mechanism of signal termination
and it should be noted that PTPs have both positive
and negative effects on the propagation of signals initi-
ated by RTKs (60). Among the multiple PTPs (60)
there is a cytosolic subclass which appears to play a
role in the transduction of cytokine induced signals.
This subclass has two members, SHP-1 (previously
called: SH-PTP1 or PTP1C) and SHP-2 (previously
called: SH-PTP2 or PTP1D), Both have SH2 domains
at their N-termini. SHP-1 has a restricted expression
pattern and is mainly found in hematopoietic cells,
while SHP-2 is more widely expressed (61).
SHP-2 appears to play a role in prolactin signal-
ing. In Nb-2 cells SHP-2, like JAK2, is associated with
the PrlR even in the absence of hormone. Mutant PrlRs
with no Tyr residues to serve as docking sites are also
associated with SHP-2 (62). Further, in cells expressing
an inactive mutant of SHP-2, prolactin induced tran-
scription of ^-casein is lower than in cells expressing
wild type SHP-2, suggesting that SHP-2 has a positive
effect upon the prolactin induced signal (62). These
results contrast dramatically with the role of SHP-1 in
cytokine signaling. SHP-1 binds to a specific phospho-
tyrosine residue in the COOH terminus of the EpoR
and is not associated with the receptor in non-stimu-
lated cells (63). SHP-1 binding to the EpoR is corre-
lated with a decrease in JAK2 phosphorylation and
cells expressing a mutant EpoR unable to bind SHP-1
are hypersensitive to Epo. These data suggest a negative
role for SHP-1 in regulation of the Epo signal and show
that despite the similarity in structure, SHP-1 and SHP-
2 have distinct functions in cytokine signaling. It is inter-
esting that Nb2 cells which express the intermediate
form of PrlR are hypersensitive to prolactin, suggesting
that another PTP which binds to the region of the PrlR
missing in the intermediate form, might be responsible
for "down-regulation" of the prolactin signal.
EXTRACELLULAR MATRIX AND
PROLACTIN
The induction of milk protein gene expression in
the mammary gland requires multiple signals including
peptide and steroid hormones as well as signals ema-
nating from the extracellular matrix (ECM) (64). In
primary cultures of mammary gland cells prolactin-
dependent Stat5 DNA binding and transcriptional acti-
vation of milk protein genes is observed only in cells
plated on a laminin-containing ECM (35). This implies
that there is a hierarchy of signaling in mammary cells
and that the ECM disposes the cells to respond to
lactogenic hormones. The HC11 cells have retained
this characteristic of primary cells. Sparse cultures of
HC11 cells do not synthesize p-casein in response to
lactogenic hormones (14). The cells must be grown
to confluency in medium containing specific growth
factors before becoming competent to respond to pro-
lactin (15,16). Growing cultures of HC11 cells deposit
an ECM which influences their ability to produce (3-
casein in response to lactogenic hormones (65). Inter-
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estingly, Stat5 is present in sparse cultures of HC11
cultures. However, prolactin treatment of these cells
does not activate Stat5 DNA binding activity (7; N.
Cella, unpublished results). This could in part be due
to the lack of an appropriate matrix, reflecting the
results seen with the primary mammary cells. The fact
that Stat5 cannot be induced to bind its cognate GAS-
like sequence in the 3-casein gene promoter under
these conditions explains the lack of ^-casein produc-
tion in sparse cultures of lactogen-treated HC11 cells.
DISCUSSION AND FUTURE QUESTIONS
The description of the cytokine inducible JAK-
Stat pathway has provided an answer to some of the
long standing questions concerning prolactin-mediated
signaling. For example, the mechanism underlying the
different signaling potentials of the various forms of
PrlR can now be explained by their ability to bind and
activate JAK2. As is usual for any novel intracellular
signaling pathway, there are now new problems to be
solved. The results described earlier suggest that there
might be two classes of PTPs involved in propagating
the prolactin signal, one important for positive regula-
tion and one involved in down-regulation of the signal.
It will be interesting to examine endogenous SHP-2
regulation in mammary epithelial cells as well as to
determine whether other PTPs might bind PrlR
directly. In addition, further analyses of primary mam-
mary cells may reveal an interesting connection
between ECM and the prolactin inducible JAK2-Stat5
pathway. The role of Ser phosphorylation in Stat5 tran-
scriptional activation also remains to be clarified. The
Ser residue as well as the kinase which phosphorylates
the site are still unknown. Stat5 proteins display con-
sensus phosphorylation sites for protein kinase C
(PKC), MAP kinase, casein kinase 2 (CK2) and cyclin
dependent kinases (see 36 for a listing of some of
these sites). The experiments with the MEK specific
inhibitor PD98059 show that MAP kinase is not
responsible for the Ser phosphorylation of Stat5. How-
ever, there is experimental evidence implicating PKC
(68,69) and CK2 (70) in the control of Stat5 activity.
In vitro treatment of nuclear extracts from lactating
mammary glands with PKC (69) or with CK2 (70)
leads to enhanced Stat5 DNA binding. These experi-
ments suggest that Ser phosphorylation together with
Tyr phosphorylation may promote optimal DNA bind-
ing activity of Stat5.
In addition to addressing new questions, some of
the older experiments in the literature can now be
reexamined in light of our current knowledge of the
JAK2-Stat5 pathway. In the past, mammary cells trans-
formed via ectopic expression of oncogenes have been
used to probe the normal intracellular signaling path-
ways involved in differentiation. The Ha-ras, v-ra/and
neu oncogenes all transform HC11 cells. However,
only the first two interfere with lactogen-induced 0-
casein expression (66,67). Transformed cells undergo
many alterations and p-casein gene expression is con-
trolled by glucocorticoids, prolactin as well as other
transcription factors (3-8). Thus, it is conceivable that
the oncogenes interfere with more than one factor
important for p-casein gene expression. However,
Stat5 DNA binding activity is impaired in Ha-ras and
v-ra/transformed cells (67) suggesting that these two
oncogenes do interfere at some step in the prolactin-
induced JAK-Stat pathway. In the future it would be
interesting to use oncogenes expressed under the con-
trol of an inducible promoter to examine early events
in the transformation process.
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